These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 21387088

  • 1. A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.
    Allameh T, Moghim S, Asadi-Zeidabadi M.
    Arch Gynecol Obstet; 2011 Dec; 284(6):1509-13. PubMed ID: 21387088
    [Abstract] [Full Text] [Related]

  • 2. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
    Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R.
    J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
    [Abstract] [Full Text] [Related]

  • 3. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.
    Elfström KM, Smelov V, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlström L, Dillner J.
    Int J Cancer; 2015 Jan 15; 136(2):350-9. PubMed ID: 24842156
    [Abstract] [Full Text] [Related]

  • 4. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
    Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group.
    J Clin Microbiol; 2013 May 15; 51(5):1458-64. PubMed ID: 23447632
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I, Chibisheva V, Micevska M, Dimitrov G.
    Med Arch; 2018 Feb 15; 72(1):26-30. PubMed ID: 29416214
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
    Otero-Motta AP, Ordóñez JL, González-Celador R, Rivas B, Macías Mdel C, Bullón A, Abad Mdel M.
    APMIS; 2011 Mar 15; 119(3):204-15. PubMed ID: 21284738
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 15; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 8. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May 15; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 9. [The role of human papillomavirus in cyto-histological practice: distribution and prevalenceof hig-risk strains (16, 18, 31, 33, and 35) in intraepithelial lesions and neoplasia of the uterine cervix].
    Voglino G, Poso F, Privitera S, Parisio F, Ghiringhello B, Gordini G, Chiara G, Massobrio M, Fessia L.
    Pathologica; 2000 Dec 15; 92(6):516-23. PubMed ID: 11234302
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
    Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG.
    PLoS One; 2015 Dec 15; 10(4):e0122488. PubMed ID: 25875167
    [Abstract] [Full Text] [Related]

  • 11. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2604-11. PubMed ID: 24740547
    [Abstract] [Full Text] [Related]

  • 12. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y, Ang Q, Wu H, Xu J, Chen D, Zhao H, Liu H, Guo X, Gu Y, Qiu H.
    Virol J; 2020 Jul 13; 17(1):104. PubMed ID: 32660490
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.
    Int J Cancer; 2012 Nov 15; 131(10):2349-59. PubMed ID: 22323075
    [Abstract] [Full Text] [Related]

  • 15. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr 15; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
    Xi LF, Touré P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB.
    Int J Cancer; 2003 Mar 01; 103(6):803-9. PubMed ID: 12516102
    [Abstract] [Full Text] [Related]

  • 17. Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
    Heydari N, Oskouee MA, Vaezi T, Shoja Z, Esmaeili HA, Hamkar R, Shahmahmoodi S, Jalilvand S.
    J Med Virol; 2018 Jan 01; 90(1):172-176. PubMed ID: 28786495
    [Abstract] [Full Text] [Related]

  • 18. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL.
    J Natl Cancer Inst; 2003 Sep 03; 95(17):1336-43. PubMed ID: 12953088
    [Abstract] [Full Text] [Related]

  • 20. Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta.
    Murdiyarso LS, Kartawinata M, Jenie I, Widjajahakim G, Hidajat H, Sembiring R, Nasar IM, Cornain S, Sastranagara F, Utomo AR.
    Cancer Causes Control; 2016 Nov 03; 27(11):1371-1379. PubMed ID: 27752850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.